ACTR confers to Sorafenib resistance in hepatocellular carcinoma via facilitating the Warburg effect.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer science"
DOI: 10.1111/cas.14412
Abstract: Sorafenib resistance is a major challenge in the therapy for advanced hepatocellular carcinoma (HCC)1 . However, the underlying molecular mechanism of HCC resistance to sorafenib remains unclear. Activator of thyroid and retinoid receptor (ACTR, also known as… read more here.
Keywords: hcc; actr; warburg effect; resistance ... See more keywords